HomeNootropics › Dynamine
Nootropic Moderate risk

Dynamine

methylliberine · Evidence-based safety and harm-reduction overview.

Not medical advice. Dynamine is discussed here for informational and harm-reduction purposes only. We do not endorse use, and any dosing context is informational, not a protocol.
Also known asmethylliberine
CategoryNootropic
half_lifeLonger than caffeine but precise human values unclear; estimated 4-6 hours
peak_onsetEstimated 30-60 minutes; head-to-head kinetic studies with caffeine limited
chemical_classPurine alkaloid, xanthine-like structure
US legal statusSold as a dietary supplement; relatively new (marketed since ~2016); legal status is stable in the US but unregulated by FDA
ADVERTISEMENT

What is Dynamine?

A naturally occurring purine alkaloid similar to caffeine, found in Kucha tea leaves. Acts as an adenosine receptor antagonist and phosphodiesterase inhibitor.

How it works

Dynamine is a xanthine-like purine alkaloid that acts as a nonselective adenosine receptor antagonist, similar to caffeine but with potentially different potency and selectivity at various receptor subtypes. It also inhibits phosphodiesterase enzymes, raising cAMP levels. The longer duration of effects compared to caffeine suggests a longer half-life or slower metabolism, though precise human pharmacokinetics remain incompletely characterized.

Background & history

Dynamine (methylliberine) is a naturally occurring alkaloid in Kucha tea leaves, a traditional plant in certain regions. It was isolated and identified in the late 20th century. Commercial supplement use began around 2016, marketed as a novel energy and mood enhancer distinct from caffeine and older xanthines.

What the research says

Emerging research, but limited human trials. Shows promise for sustained energy and mood; marketed as smoother and longer-lasting than caffeine. Most efficacy claims are preliminary.

Reported effects

Dosing & administration (informational)

Commercial dynamine supplements typically contain 50-150 mg per serving. No established clinical dosing exists from human trials. Formulas often combine dynamine with caffeine (100-200 mg) to enhance and sustain stimulation, though human safety of such combinations is minimally studied.

This is general research/context information, not medical advice or a recommended protocol.

Safety & side effects

Drug & supplement interactions

Who should avoid it

How it is commonly combined

Dynamine is commonly stacked with caffeine to produce sustained, synergistic stimulation. Such combinations raise overall stimulant load and should be approached cautiously. Medical guidance is prudent, especially for individuals with cardiac sensitivity.

Quality & harm reduction

Safer, legal alternative we recommend

Caffeine in moderation. Decades of safety data, well-understood effects, and proven efficacy; stick with what is known until dynamine safety is more established.

See our recommended pick

Lab testing & harm-reduction tools

If you are going to research a compound, verifying identity and purity is the single most protective step. Independent analytical testing and sterile-handling supplies reduce risk.

Compare testing options
ADVERTISEMENT

Frequently asked questions

Is dynamine better than caffeine?

Different, not necessarily better. Dynamine may provide smoother, longer-lasting effects for some users, but rigorous head-to-head trials are limited.

Is dynamine safe long-term?

Preliminary data suggest it is likely safe, but long-term human studies are lacking. Treat as relatively new and monitor for unexpected effects.

Can I combine dynamine and caffeine?

Users report synergistic effects, but this combination raises stimulant load and cardiovascular stress. Caution and medical consultation recommended.

Where does dynamine come from?

Dynamine is a naturally occurring purine alkaloid found in Kucha tea leaves and related plants. It is extracted and concentrated for commercial supplements.

How long has dynamine been studied?

Dynamine is relatively new to Western supplement markets (circa 2016). Published human safety and efficacy data are limited; long-term effects remain unknown.

References & further reading

  1. Naturally present in Kucha tea leaves and related plants
  2. Limited peer-reviewed human efficacy and safety trials; mostly preliminary data and marketing claims
  3. Patent literature and pre-clinical studies available but not yet extensive long-term human data
  4. Emerging supplement ingredient with growing but still limited scientific foundation

Medical & legal disclaimer. This site is for informational and harm-reduction purposes only. It is not medical advice and is not a substitute for a licensed healthcare professional. The compounds discussed are largely not approved by the FDA for human use and many are sold strictly as research chemicals 'not for human consumption.' Nothing here is an endorsement to purchase, possess, or use any substance. Laws vary by jurisdiction. Always consult a qualified physician and follow the law where you live.

Some links on this page may be affiliate links. If you buy through them we may earn a commission at no extra cost to you. This never changes the safety information we publish.